Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immunologically Effective Chiral Polymers to Potentiate Anti-Cancer Immune Responses.

Polymer science & technology (Washington, D.C.)·2026

Same author

Synthetic Polymers for Drug, Gene, and Vaccine Delivery.

Polymer science & technology (Washington, D.C.)·2026

Same author

Prospects of Four-Dimensional Printing of Polymers for Biomedical Engineering.

Polymer science & technology (Washington, D.C.)·2026

Same author

Antioxidant Proline Carbon Dot-Composited Poly(L-methionine) Hydrogel Restores Mitophagy to Alleviate Cellular Senescence in Intervertebral Disc Degeneration.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan-Tissue Antigen-Presenting Cells Enables Durable in situ mRNA Cancer Immunotherapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Thermo-sensitive poly(L-methionine) hydrogel facilitates regenerative repair of diabetic wounds by modulating immune microenvironments.

Biomaterials science·2026

Same journal

A Muscle-Mimetic Core-Sheath Composite Yarn Scaffold for In-Body Tissue Induction and Regeneration of Small-Diameter Vascular Grafts.

Advanced healthcare materials·2026

Same journal

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Advanced healthcare materials·2026

Same journal

Therapeutic Extracellular Vesicles from Synovial Fibroblast-Primed MSCs for Osteoarthritis Treatment.

Advanced healthcare materials·2026

Same journal

Natural Polysaccharide-Mediated Nano-Delivery Systems for Osteoporosis Therapy From a Gut-Bone Axis Regulatory Perspective.

Advanced healthcare materials·2026

Same journal

A Corrigendum on "Selenium-Albumin Nanoaccelerator Hydrogel Promotes Wound Healing by Antibacterial, Anti-Inflammatory and Antioxidant along with Inhibits Scar Formation via Down-regulating CD36".

Advanced healthcare materials·2026

Same journal

High-Throughput Digital Decoding of Vascular Heterogeneity in Patient-Specific Tumor Microenvironments.

Advanced healthcare materials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 25, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Biomaterials-Boosted Immunotherapy for Osteosarcoma.

Chao Sun^1,2, Shuqiang Li¹, Jianxun Ding²

¹Department of Orthopedic Surgery, Orthopedic Center, The First Hospital of Jilin University, 1 Xinmin Street, Changchun, 130061, P. R. China.

Advanced Healthcare Materials

|May 21, 2024

Summary

This summary is machine-generated.

Biomaterials can enhance immunotherapy for osteosarcoma (OS) by reprogramming the tumor microenvironment. This approach offers a promising strategy for improving treatment effectiveness and patient outcomes in OS.

Keywords:

biomaterial immune cell phenotype regulation immune checkpoint blockade osteosarcoma immunotherapy tumor microenvironment modulation

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Related Experiment Videos

Last Updated: Jun 25, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

Area of Science:

Oncology
Biomaterials Science
Immunotherapy

Background:

Osteosarcoma (OS) is a primary bone cancer with high recurrence and metastasis rates, challenging current treatments.
Existing therapies focus on tumor resection and symptom management, often failing to eradicate malignant cells.
Novel therapeutic strategies are needed to improve patient prognosis and treatment efficacy for OS.

Purpose of the Study:

To review the mechanisms of osteosarcoma treatment, focusing on biomaterials-enhanced tumor immunity.
To summarize immune cell phenotypes and tumor microenvironment regulation in OS.
To explore the role of immune checkpoint blockade in activating the immune system against OS.

Main Methods:

Literature review of biomaterials-boosted immunotherapy for osteosarcoma.
Analysis of tumor microenvironment modulation by biomaterials.
Examination of immune cell phenotypes and immune checkpoint blockade efficacy.

Main Results:

Biomaterials-boosted immunotherapy shows high effectiveness and a favorable safety profile for OS.
This approach manipulates the tumor microenvironment to impede tumor progression.
Understanding these mechanisms is key to developing improved immunotherapy protocols.

Conclusions:

Biomaterials-enhanced immunotherapy represents a promising therapeutic avenue for osteosarcoma.
Further research into biomaterials-boosted immunotherapy can lead to more efficacious treatment options.
A deeper comprehension of immune modulation in OS is crucial for advancing treatment strategies.